Failure of acute rejection reversal · kidney transplant recipients: first rejection episode
Antibody (T cell) probably leads to lower failure of reversal of acute rejection compared with steroid (stratified by antibody type) (moderate certainty).
1 finding from 1 review
Recurrent rejection · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in recurrent rejection compared with steroid (stratified by antibody type) (moderate certainty).
1 finding from 1 review
Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in graft loss or death with a functioning graft compared with steroid (stratified by antibody type) (low certainty).
1 finding from 1 review
Graft loss censored for death · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in graft loss censored for death compared with steroid (stratified by antibody type) (low certainty).
1 finding from 1 review
Death · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes death compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
Treatment adverse events: fever, chills, malaise after drug administration · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes treatment adverse events: fever, chill, or malaise after drug… compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
All‐cause mortality · lung transplant recipients
T‐cell antibody induction showed no clear difference in mortality compared with no antibody induction (moderate certainty).
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
T‐cell antibody induction showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Infection · lung transplant recipients
T‐cell antibody induction showed no clear difference in infection compared with no antibody induction (moderate certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
1 finding from 1 review
All‐cause mortality · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in mortality compared with no antibody induction (moderate certainty).
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Infection · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in infection compared with no antibody induction (moderate certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
1 finding from 1 review
Mortality Mortality at latest · liver transplant recipients
T‐cell antibody induction showed no clear difference in mortality Mortality at latest compared with corticosteroid induction (low certainty).
1 finding from 1 review
Graft loss including death · liver transplant recipients
T‐cell antibody induction showed no clear difference in graft loss Graft loss (including death with a functioning graft) at… compared with corticosteroid induction (low certainty).
1 finding from 1 review
Acute rejection · liver transplant recipients
T‐cell antibody induction showed no clear difference in acute rejection Number of participants who experienced at least 1… compared with corticosteroid induction (low certainty).
1 finding from 1 review
Infection Number of participants who experienced at least 1 episode of infection · liver transplant recipients
T‐cell antibody induction showed no clear difference in infection Number of participants who experienced at least 1 episode… compared with corticosteroid induction (low certainty).
1 finding from 1 review
CMV infection · liver transplant recipients
T‐cell antibody induction may leads to lower cytomegalovirus infection Number of participants who experienced at… compared with corticosteroid induction (low certainty).
1 finding from 1 review
Hepatitis C recurrence Number of participants diagnosed with hepatitis C virus recurrence · liver transplant recipients
T‐cell antibody induction showed no clear difference in hepatitis C recurrence Number of participants diagnosed with… compared with corticosteroid induction (low certainty).
1 finding from 1 review